Miami Cardiometabolic Summit: Practical Updates in Preventive and Clinical Cardiology

Miami Cardiometabolic Summit: Practical Updates in Preventive and Clinical Cardiology is organized by Baptist Health South Florida and will be held During Feb 22 - 24, 2018 at Nobu Hotel Miami Beach, Miami Beach, Florida, United States of America.

The target audience for this medical event is Cardiologists, General Internists, Family Physicians, Emergency Medicine and Urgent Care Physicians, Obstetricians, Gynecologists, Psychologists, Physician Assistants, Nurse Practitioners, Nurses, Social Workers and Mental Health Counselors, Radiation Technologists, Sonographers, Dietitians and Pharmacists and all other healthcare professionals who care for patients who wish to prevent – or who have been diagnosed with – cardiac, vascular or metabolic risks, disorders or diseases. This CME Conference has been approved for a maximum of 11.5 AMA PRA Category 1 Credits.

The Cardiometabolic Summit provides a comprehensive review of the latest breakthroughs, advances and innovations in preventive and general cardiac and vascular medicine. Expert faculty will explore patient management approaches to the assessment and reduction of cardiovascular disease risk and cost-effective solutions in preventive cardiology. Through focused presentation sessions and panel discussions, they will provide practical patient care management approaches as they address integrative medicine, recent guideline changes, expert consensus updates, lifestyle management, hypertension treatment, advanced coronary artery disease management, and new perspectives on the diabetic heart.

Participants will implement practical approaches to common and important cardiometabolic challenges utilizing the latest evidence-based screening guidelines and treatment approaches to achieve reduction of cardiovascular disease risk.

Learning Objectives are:
Upon completion of this summit, participants should be better able to:
• Address the persistent sex-specific gaps found in guidelines, recommendations and prevention of cardiovascular disease strategies for women, and recognize diagnostic and therapeutic adherence.
• Define the differences in coronary artery disease patterns in women and its impact on prognosis.
• Recognize sex-specific risk factors that affect women and identify that these risk factors are part of the risk assessment.
• Recognize the risk factors associated with asymptomatic carotid atherosclerotic disease, and examine the evidence that supports a conservative approach to carotid revascularization in asymptomatic patients.
• Examine the results of the REVEAL trial and explain how cholesterol ester transfer protein (CETP) inhibitors have shown neutral or adverse effects on cardiovascular outcomes.
• Examine and implement the National Lipid Association recommendations for patient-centered management of dyslipidemia.
• Cite the clinical trial evidence supporting the use of omega-3 fatty acids in cardiovascular disease prevention.
• Review the randomized clinical trials currently evaluating the incremental benefit of adding omega-3 fatty acids to statin therapy in high-risk patients with elevated triglycerides.
• Examine the evidence that reveals how meditation promotes health and well-being.
Implement strategies to effectively motivate smoking cessation behaviors in patients, and examine pharmacologic options for smoking cessation therapies.
• Implement practical treatment protocols for the management of obesity from the point of view of the practicing physician.
• Explain the role of bariatric surgery and its impact in obese individuals diagnosed with diabetes and cardiovascular diseases.
• Initiate effective patient education discussions about the minimal level of exercise needed for improved health.
• Recognize components of the optimal diet for cardiovascular health, and explain the scientific evidence behind popular weight loss diets.
• Examine the formal evidence from the FOURIER trial, and explain how targeted treatment at PCSK9 inhibition confers additional cardiovascular benefits beyond lipid-lowering treatment alone.
• Recognize the key differences and controversies among the multitude of hypertension practice guidelines, and discuss the different rationales for variable BP goals.
• Examine the impact of adding empagliflozin to standard care of type 2 diabetes patients who are at high risk for cardiovascular events.
• Examine the current results of the CANTOS study and explain how targeting inflammation produces a direct benefit on patient outcomes.
• Evaluate the implications of the absence of coronary artery calcium (CAC) in reclassifying patients from a risk stratum in which statins are recommended to one in which they are not.
• Examine statin-associated muscular adverse events, and explain how such events are typically temporal due to the initiation of statin therapy.
• Describe and recognize the usefulness of stress testing in patients with suspected coronary artery disease.
• Examine the role of coronary computed tomographic angiography as a diagnostic tool in the evaluation of patients with chest pain.
• Recognize the strong association atrial fibrillation has with other cardiovascular diseases in order to properly manage, diagnose and treat.
• Examine prevention, reversal and treatment strategies for heart failure, considering medical and surgical options.
• Assess the long-term vital prognosis of patients with abdominal aortic aneurysmal disease or peripheral artery disease to determine possible differences in survival, prognostic risk profiles and causes of death.
• Examine the primary causes of aortic stenosis, its progression and risks, and recognize the diagnostic tests and treatment options available.